Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

By Schilder R.J.   Brady M.F.   Spriggs D.   Shea T.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 3-8

Academic Press

Access to resources Recommend Favorite

High-dose Melphalan with Re-infusion of Unprocessed, G-CSF-primed Whole Blood is Effective and Non-toxic Therapy in Multiple Myeloma

By Ossenkoppele G.J.   Schuurhuis G.J.   Jonkhoff A.R.   van der Hem K.G.   Legdeur M.C.J.C.   Boot-Bakker A.   Westra A.H.   Drager A.M.   Huijgens P.C.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2058-2063

Elsevier

Access to resources Recommend Favorite

Repetitive High-Dose Topotecan, Carboplatin, and Paclitaxel with Peripheral Blood Progenitor Cell Support in Previously Untreated Ovarian Cancer: Results of a Phase I Study

By Prince H.M.   Rischin D.   Quinn M.   Allen D.   Planner R.   Neesham D.   Gates P.   Davison J.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 216-224

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy combined with autologous peripheral blood stem cell transplantation in children with advanced malignant solid tumors: A retrospective analysis of 38 cases

By                  

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1047-1053

Spandidos Publications

Access to resources Recommend Favorite

High-dose chemotherapy followed by peripheral and/or bone marrow stem cell transplant in patients with advanced sarcoma: experience of a Canadian Centre

By Hotte Sébastien J.  

Sarcoma, Vol. 8, Iss. 2-3, 2004-06 ,pp. : 63-69

Informa Healthcare

Access to resources Recommend Favorite